ACTON, Mass. (AP) — ACTON, Mass. (AP) — Insulet Corp. (PODD) on Wednesday reported fourth-quarter profit of $101.6 million.
The Acton, Massachusetts-based company said it had net income of $1.44 per share. Earnings, adjusted for one-time gains and costs, came to $1.55 per share.
The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.48 per share.
The maker of insulin infusion systems posted revenue of $783.8 million in the period, also beating Street forecasts. Ten analysts surveyed by Zacks expected $767.3 million.
For the year, the company reported profit of $247.1 million, or $3.48 per share. Revenue was reported as $2.71 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PODD at https://www.zacks.com/ap/PODD
/AI%20(artificial%20intelligence)/AI%20microchip%20by%20DesignKingBD360%20via%20Shutterstock.jpg)
/2d%20illustration%20of%20Cloud%20computing%20by%20Blackboard%20via%20Shutterstock.jpg)
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)